Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Cristina Cox

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Diseases (Basel, Switzerland)|December 24, 2025
Health-Related Quality of Life and Symptom Burden in Patients with Diffuse Large B-Cell Lymphoma Before Treatment with Tafasitamab and Lenalidomide: An Ad Hoc Analysis of Italian Real-World Data from the PRO-MIND StudyPier Luigi Zinzani, Nicola Battaglia, Mario Lapecorella, et al.
Journal of Neuro-Oncology|August 29, 2006
Intrathecal anti-CD20 antibody: an effective and safe treatment for leptomeningeal lymphomaGiovanni Antonini, Maria Cristina Cox, Enrico Montefusco, et al.
Plastic and Reconstructive Surgery|July 29, 2015
Breast Implant-Associated Anaplastic Large Cell Lymphoma: Proposal for a Monitoring ProtocolFabio Santanelli di Pompeo, Rosaria Laporta, Michail Sorotos, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|January 28, 2004
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantationAlessandra Picardi, Paolo de Fabritiis Pd, Laura Cudillo, et al.
Leukemia & Lymphoma|September 23, 2014
Lenalidomide monotherapy in heavily pretreated patients with non-Hodgkin lymphoma: an Italian observational multicenter retrospective study in daily clinical practicePier Luigi Zinzani, Luigi Rigacci, Maria Cristina Cox, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 18, 2002
Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumorsAntonio Bruno, Tommaso Caravita, Gaspare Adorno, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Diseases (Basel, Switzerland)|December 24, 2025
Health-Related Quality of Life and Symptom Burden in Patients with Diffuse Large B-Cell Lymphoma Before Treatment with Tafasitamab and Lenalidomide: An Ad Hoc Analysis of Italian Real-World Data from the PRO-MIND StudyPier Luigi Zinzani, Nicola Battaglia, Mario Lapecorella, et al.
Journal of Neuro-Oncology|August 29, 2006
Intrathecal anti-CD20 antibody: an effective and safe treatment for leptomeningeal lymphomaGiovanni Antonini, Maria Cristina Cox, Enrico Montefusco, et al.
Plastic and Reconstructive Surgery|July 29, 2015
Breast Implant-Associated Anaplastic Large Cell Lymphoma: Proposal for a Monitoring ProtocolFabio Santanelli di Pompeo, Rosaria Laporta, Michail Sorotos, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|January 28, 2004
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantationAlessandra Picardi, Paolo de Fabritiis Pd, Laura Cudillo, et al.
Leukemia & Lymphoma|September 23, 2014
Lenalidomide monotherapy in heavily pretreated patients with non-Hodgkin lymphoma: an Italian observational multicenter retrospective study in daily clinical practicePier Luigi Zinzani, Luigi Rigacci, Maria Cristina Cox, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 18, 2002
Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumorsAntonio Bruno, Tommaso Caravita, Gaspare Adorno, et al.
Pageof 1